On this page
Update: January 2022
Forms and strengths
- 100 mg and 400 mg tablets
- 100 mg dispersible tablet, to be dispersed in 10 ml water
Dosage
- Child and adult: 15 to 25 mg/kg once daily
- Maximum dose: 1200 mg daily
- Renal insufficiency: 15 to 25 mg/kg 3 times a week
|
Weight |
Daily dose |
400 mg |
100 mg |
|---|---|---|---|
|
5 |
75-125 |
− |
1 tab |
|
6 |
90-150 |
− |
1 tab |
|
7 |
105-175 |
− |
1 tab |
|
8 |
120-200 |
− |
2 tab |
|
9 |
135-225 |
− |
2 tab |
|
10 |
150-250 |
− |
2 tab |
|
11 |
165-275 |
− |
2 tab |
|
12 |
180-300 |
− |
2 tab |
|
13 |
195-325 |
− |
2 tab |
|
14 |
210-350 |
− |
3 tab |
|
15 |
225-375 |
− |
3 tab |
|
16 |
240-400 |
− |
3 tab |
|
17 |
255-425 |
− |
3 tab |
|
18 |
270-450 |
1 tab |
− |
|
19 |
285-475 |
1 tab |
− |
|
20 |
300-500 |
1 tab |
− |
|
21 |
315-525 |
1 tab |
− |
|
22 |
330-550 |
1 tab |
− |
|
23 |
345-575 |
1 tab |
− |
|
24 |
360-600 |
1 tab |
− |
|
25 |
375-625 |
1 tab |
− |
|
26 |
390-650 |
1 tab |
− |
|
27 |
405-675 |
1½ tab |
− |
|
28 |
420-700 |
1½ tab |
− |
|
29 |
435-725 |
1½ tab |
− |
|
|
|||
|
30-35 |
800 |
2 tab |
− |
|
36-45 |
800 |
2 tab |
− |
|
46-55 |
1200 |
3 tab |
− |
|
56-70 |
1200 |
3 tab |
− |
|
> 70 |
1200 |
3 tab |
− |
Contra-indications, adverse effects, precautions
- Do not administer to patients with severe renal impairment or optic neuritis (e.g. diabetic retinopathy).
- May cause:
- dose-related retrobulbar optic neuritis, exarcerbated in renal impairment;
- hypersensitivity reactions.
- The dosage must be carefully adjusted to the weight, especially for children under 5 years, as it is more difficult to detect visual changes at this age.
- For the management of adverse effects, see Appendix 17.
- Pregnancy: no contra-indication
- Breastfeeding: no contra-indication
Monitoring
- Symptomatic monitoring.
Patient instructions
- Take with or without food.
- 100 mg dispersible tablets should be dispersed in 10 ml water.
Remarks
- For adults on drug-susceptible TB treatment, ethambutol is given as part of a fixed-dose combination.
- Ethambutol is also used in the treatment of drug-resistant TB treatment for longer duration. For treatment > 2 months, daily doses should be closer to 15 mg/kg and visual acuity and colour discrimination should be monitored.
Storage
–
– Below 25 °C